1. Efficacy and Safety of a Six-Hour Continuous Overlap Method for Converting Intravenous to Transdermal Fentanyl in Cancer Pain 
Renato V. Samala, MD, Rafael Bloise, MD, Mellar P. Davis, MD 
Journal of Pain and Symptom Management 
Volume 48, Issue 1, Pages (July 2014)
DOI: /j.jpainsymman
Copyright © 2014 U.S. Cancer Pain Relief Committee Terms and Conditions

2. Fig. 1
Median pain intensity ratings before TF placement (zero hours) and six, 12, 18, and 24 hours thereafter. TF=transdermal fentanyl.
Journal of Pain and Symptom Management  , DOI: ( /j.jpainsymman )
Copyright © 2014 U.S. Cancer Pain Relief Committee Terms and Conditions

3. Fig. 2
Median number of rescue analgesic doses before TF placement (zero hours) and six, 12, 18, and 24 hours thereafter. TF=transdermal fentanyl.
Journal of Pain and Symptom Management  , DOI: ( /j.jpainsymman )
Copyright © 2014 U.S. Cancer Pain Relief Committee Terms and Conditions